Viewing Study NCT03038503

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:18 PM
Ignite Modification Date: 2026-02-28 @ 7:12 PM
Study NCT ID: NCT03038503
Status: UNKNOWN
Last Update Posted: 2018-08-29
First Post: 2016-12-22
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: What Should be the Next Vasopressor for Severe Septic Shock? Methylene Blue or Terlipressin
Sponsor: Ramathibodi Hospital
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Septic Shock View
None Refractory Shock View
Keywords:

Keywords

Keyword Brief Keyword Text View
None refractory septic shock View
None catecholamine resistance septic shock View
None terlipressin View
None methylene blue View